EMILY CRAWFORD: Open Payments
NPI 1669654190 · BRYSON CITY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$732 in 46 payments from 10 companies in 2025. Trend: 2023 $1,537 · 2024 $867 · 2025 $732
Food & beverage: $732
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $192 |
| PFIZER INC. | 9 | $142 |
| AstraZeneca Pharmaceuticals LP | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| Lilly USA, LLC | 3 | $55 |
| Amgen Inc. | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $45 |
| Corcept Therapeutics | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $13 |
Products named: VRAYLAR, NURTEC ODT, REXULTI, Kerendia, JARDIANCE, XIFAXAN, AIRSUPRA, QULIPTA.
Industry payments across NC — which companies pay providers there.
